Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis

British Journal of Cancer

Volumn 99, Issue 1, 2008, Pages 160-166

  Arrieta, O ^a   Pineda Olvera, B ^b   Guevara Salazar, P ^b   Hernandez Pedro N ^a   Morales Espinosa, D ^a   Ceron Lizarraga T L ^a   Gonzalez De La Rosa C H ^c   Rembao, D ^b   Segura Pacheco, B ^a   Sotelo, J ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c DEPARTAMENTO DE PROCESOS Y TECNOLOGÍA   (Mexico)

Author keywords

Angiogenesis; Angiotensin receptors; Astrocytomas; Prognosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 46349102280     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604431     Document Type: Article

References (57)

1. Andrade SP, Cardoso CC, Machado RD, Beraldo WT (1996) Angiotensin-II-induced angiogenesis in sponge implants in mice. Int J Microcirc Clin Exp 16: 302-307
2. Ariza A, Fernandez LA, Inagami T, Kim JH, Manuelidis EE (1988) Renin in glioblastoma multiforme and its role in neovascularization. Am J Clin Pathol 90: 437-441
3. Arrieta O, Garcia E, Guevara P, Garcia-Navarrete R, Ondarza R, Rembao D, Sotelo J (2002) Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 94: 3210-3218
4. Arrieta O, Guevara P, Escobar E, García-Navarrete R, Pineda B, Sotelo J (2005) Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer 92: 1247-1257
5. Batchelor TT, Betensky RA, Esposito JM (2004) Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 10: 228-233
6. Booz GW, Conrad KM, Hess AL, Singer HA, Baker KM (1992) Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology 130: 3641-3649
7. Brink M, Chrast J, Price SR, Mitch WE, Delafontaine P (1999) Angiotensin II stimulates gene expression of cardiac insulin-like growth factor 1 and its receptor through effects on blood pressure and food intake. Hypertension 34: 1053-1059
8. Chua CC, Hamdy RC, Chua BH (1998) Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1401: 187-194
9. Cook JL, Giardina JF, Zhang Z, Re R (2002) Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. J Mol Cell Cardiol 34: 1525-1537
10. Deshayes F, Nahmias C (2005) Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 16: 293-299
11. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlöf B, Deanfield J, Diez J, Drexler H, Ferrari R, van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Lüscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, Weber M (2001) The relevance of tissue angiotensin converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 88: 1L-20L
12. Egami K, Murohara T, Shimada T, Sasaki K-i, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, Imaizumi T (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112: 67-75
13. Escobar E, Rodriguez-Reyna TS, Arrieta O, Sotelo J (2004) Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol Rev 2: 385-399
14. Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105: 141-145
15. Fogarty DJ, Matute C (2001) Angiotensin receptor-like immunoreactivity in adult brain white matter astrocytes and oligodendrocytes. Glia 35: 131-146
16. Fogarty DJ, Sánchez-Gómez MV, Matute C (2002) Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitro. Glia 39: 304-313
17. Fujimoto Y, Sasaki T, Tsuchida A, Chayama K (2001) Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 495: 197-200
18. Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M (2005) Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26: 271-279
19. Gallagher PE, Tallant EA (2004) Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 25: 2045- 2052
20. Ganong WF (1984) The brain renin-angiotensin system. Annu Rev Physiol 46: 17-31
21. Ganong WF (1995) Coda, tissue renin-angiotensin systems, 1994. Adv Exp Med Biol 377: 435-440
22. Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H, Desbaillets I, Nozaki M, Diserens AC, Hamou MF, Dietrich PY, Regli L, Janzer RC, Bucher P, Stupp R, de Tribolet N, Domany E, Hegi ME (2003) Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 63: 6613-6625
23. Haddad GE, Blackwell K, Bikhazi A (2003) Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist. Can J Physiol Pharmacol 81: 142-149
24. Hamaguchi A, Kim S, Izumi Y, Zhan Y, Yamanaka S, Iwao H (1999) Contribution of extracellular signal-regulated kinase to angiotensin ii-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. Hypertension 34: 126-131
25. Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T, Kitamura H, Umemura S (2007) Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis. Lab Invest 87: 189-198
26. Ino K, Shibata K, Kajiyama H, Yamamoto E, Nagasaka T, Nawa A, Nomura S, Kikkawa F (2006) Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. Br J Cancer 27: 552-560
27. Ino K, Uehara C, Kikkawa F, Kajiyama H, Shibata K, Suzuki T, Khin EE, Ito M, Takeuchi M, Itakura A, Mizutani S (2003) Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase C- and mitogen-activated protein kinase-dependent signaling pathway. J Clin Endocrinol Metab 88: 3973-3982
28. Juillerat-Jeanneret L, Celerier J, Chapuis Bernasconi C, Nguyen G, Wostl W, Maerki HP, Janzer RC, Corvol P, Gasc JM (2004) Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer 90: 1059-1068
29. Kagami S, Border WA, Miller DE, Noble NA (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437
30. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C (2006) Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 118: 2182-2189
31. Khachigian LM, Takuwa Y, Collins T (2000) Mechanisms of angiotensin II-induced platelet derived growth factor gene expression. Mol Cell Biochem 212: 183-186
32. Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, Struyker Boudier HA (1991) Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 195: 305-306
33. Lee DK, Lança AJ, Cheng R, Nguyen T, Ji XD, Gobeil Jr F, Chemtob S, George SR, O'Dowd BF (2004) Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 27: 7901-7908
34. Lopez-Gonzalez MA, Sotelo J (2000) Brain tumors in Mexico: characteristics and prognosis of glioblastoma. Surg Neurol 53: 157-162
35. Lu D, Yang H, Shaw G, Raizada MK (1998) Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1). receptor in brain neurons. Endocrinology 139: 365-375
36. Matsusaka T, Ichikawa I (1997) Biological functions of angiotensin and its receptors. Annu Rev Physiol 59: 395-412
37. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial. J Clin Oncol 24: 2563-2569
38. Miyajima A, Kosaka T, Asano T, Asano T, Seta K, Kawai T, Hayakawa M (2002) Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis. Cancer Res 62: 4176-4179
39. Moriyama T, Kataoka H, Koono M, Wakisaka S (1999) Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors. Int J Mol Med 3: 531-536
40. Nahmias C, Strosberg AD (1995) The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function. Trends Pharmacol Sci 16: 223-225
41. Ohta K, Kim S, Hamaguchi A, Yukimura T, Miura K, Takaori K, Iwao H (1994) Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats. Eur J Pharmacol 269: 115-119
42. Otani A, Takagi H, Oh H, Koyama S, Honda Y (2001) Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 50: 867-875
43. Otani A, Takagi H, Suzuma K, Honda Y (1998) Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 82: 619-628
44. Peng H, Moffett J, Myers J, Fang X, Stachowiak EK, Maher P, Kratz E, Hines J, Fluharty SJ, Mizukoshi E, Bloom DC, Stachowiak MK (2001) Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell 12: 449-462
45. Reardon DA, Rich JN, Friedman HS, Bigner DD (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24: 1253-1265
46. Rivera E, Arrieta O, Guevara P, Duarte-Rojo A, Sotelo J (2001) AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br J Cancer 85: 1396-1399
47. Schmidt N, Westphal M, Hagel C, Ergün S, Stavrou D, Rosen EM, Lamszus K (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 84: 10-18
48. Sotelo J, Briceño E, Lopez-Gonzalez MA (2006) Adding chloroquine to conventional treatment for glioblastoma multiforme: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med 144: 337-343
49. Stoll M, Steckelings U, Paul M, Bottari S, Metzger R, Unger T (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657
50. Strugar J, Criscuolo G, Rothbart D, Harrington WN (1995) Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 83: 682-689
51. Takeda H, Kondo S (2001) Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 158: 1633- 1637
52. Tamarat R, Silvestre JS, Durie M, Levy BI (2002) Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82: 747-756
53. Touyz RM, Berry C (2002) Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015
54. Tuettenberg J, Friedel C, Vajkoczy P (2006) Angiogenesis in malignant glioma - a target for antitumor therapy? Crit Rev Oncol Hematol 59: 181-193
55. Uemura H, Ishiguro H, Nagashima Y, Sasaki T, Nakaigawa N, Hasumi H, Kato S, Kubota Y (2005) Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol Cancer Ther 4: 1699-1709
56. Weigert C, Brodbeck K, Klopfer K, Häring HU, Schleicher ED (2002) Angiotensin II induces human TGF-β1 promoter activation: similarity to hyperglycaemia. Diabetologia 45: 890-898
57. Yao Y, Kubota T, Sato K, Kitai R, Takeuchi H, Arishima H (2001) Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours. Acta Neurochir (Wien) 143: 159-166